MR 889

Known as: MR-889, MR889 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2002
0119892002

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
Chronic obstructive pulmonary disease, characterised by a slowly progressive, irreversible airways limitation, is a major… (More)
Is this relevant?
1996
1996
We investigated whether MR889, a synthetic cyclic thiolic elastase inhibitor, administered for a period of 4 weeks to chronic… (More)
  • table 1
  • table 2
Is this relevant?
1994
1994
MR889 is a synthetic inhibitor of human neutrophil elastase with potential in clinical conditions characterized by a high load of… (More)
Is this relevant?
1992
1992
In order to unravel the serine proteinase inhibition mechanism by cyclic thiolic compounds, the X-ray crystal structure of bovine… (More)
Is this relevant?
1990
1990
The cyclic thiolic compound 2-[3-thiophencarboxythio]-N-[dihydro-2(3H)-thiophenone-3-il] - propionamide (MR889) was investigated… (More)
Is this relevant?
1989
1989
We investigated the proteinase inhibitory activity of MR 889, a thiolactic acid derivative. It is able to in vitro inhibit at low… (More)
Is this relevant?